期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

孤独症异常行为问题的精神药物治疗进展 被引量：2

原文传递
导出
摘要 儿童孤独症属于广泛性发育障碍的一种。与疾病伴随的兴奋,易怒,冲动及多动行为问题较为多见,也成为现阶段药物治疗的主要靶症状。本文从孤独症伴随的情绪及行为问题,以及相应的药物治疗进展作一综述。
作者 李雪蓉 康传媛
机构地区 昆明医科大学第一附属医院精神科
出处 《国际精神病学杂志》 2013年第3期179-182,共4页 Journal Of International Psychiatry
基金 昆明医学院"十二五"校级重点建设学科(精神病与精神卫生学)经费资助
关键词 儿童孤独症 异常行为 精神药物 进展
分类号 R749.05 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献15

  • 1American Psychiatric Association. Diagnostic and Statistical Manual of Mental Dosorders, Fourth Edition, Text Revision, Washington, DC : American Psychiatric Association; 2000.
  • 2Aman MG, Van Bourgondien ME, Wolford P, et al. Psycho- tropic and anticonvulsant drugs in subjects with autism:Preva- lence and patterns of use. Journal of the American Academy of Child and Adolescent Psychiatry, 1995 ;34(12) : 1672-1681.
  • 3Ming X, Brimaconbe M, Chaaban J, et al. Autism spectrum disorders:concurrent clinical diaorders. J Child Neurol. 2008; 23(1) :6-13.
  • 4Lecavalier L. Behavioral and emotional problems in young peo- ple with pervasive developmental disorders: relative preva- lence, effects of subject characteristics and empirical classifi- cation. J Autism Dev Disord . 2006 ; 36 : 1101-1114.
  • 5Matson JL, Nebel-Schwalm M. Assessing challenging behav- iors in children with autism spectrum disorders: a review. Res Dev Disabil. 2007 ;28(6) :567-579.
  • 6McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5) :314-321.
  • 7Eugene LA,Cristan F. Moderarors, Medistors, and Other Pre- dictors of Rrisperidone Response in Children with Autistic Disorder and Irritability. J Child Adolesc Psychopharmacol. 2010 ;20(2) :83-93.
  • 8韦斌垣,黄飞,覃小田,梁巧琦.利培酮在治疗孤独症儿童行为问题中的作用[J].中国当代儿科杂志,2011,13(3):216-218. 被引量：15
  • 9Adelaide SR, Candace A, Elizabeth EB, et al. Safety and Tol- erability of Aripiprazole in the Treatment of Irritability Associ- ated With Autistic Disorder in Pediatric Subjects (6-17 Years Old) :Results From a Pooled Analysis of 2 Studies. Prim Care Companion CNS Disord. 2011 ; 13(1) :el-e9.
  • 10Marcus RN, Owen R, Manos G,et al. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, muhicenter study. J Clin Psychiatry,2011 ;72 (9) : 1270-1276.

二级参考文献13

  • 1Stehr Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association[J]. Am J Prev Med, 2003, 25(2) :101- 106.
  • 2Posey DJ,Walsh KH,Wilson GA, McDougle CJ. Risperidone in the treatment of two very young children with autism [ J ]. J Child Adolesc Psychopharmacol, 1999, 9 (4) :273-276.
  • 3Malone RP, Maislin G, Choudhury MS, Gifford C, Delaney MA. Risperidone treatment in children and adolescents with autism: short-and long-term safety and effectiveness[ J ]. J Am Acad Child Adolesc Psych, 2002, 41 (2) :140-147.
  • 4Tankosic T. Autism: Expanding R&D and clinical trials[J]. Drug Market Development, 2007, 18 (5) :20-25.
  • 5Stachnik JM, Nunn-Thompson C. Use of atypical antipsychoties in the treatment of autistic disorder[ J ]. Ann Pharmacother, 2007, 41 (4) :626-634.
  • 6Tyson PJ, Roberts KH, Mortimer AM. Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors? [J]. Int J Neurosci, 2004, 114(6) :5934511.
  • 7Fombonne E. Risperidone improves restricted, repetitive, and ster-eotyped bebaviour in autistic children and adolescents [ J ]. Evid Based Ment Health, 2006, 9( 1 ) :6.
  • 8McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, et al. Risperidone in children with autism and serious behavioral problems[J]. N Engl J Med, 2002, 347(5) :314-321.
  • 9Veenstra-Vander Weele J, Anderson GM, Cook EH Jr. Pharmaco-genetics and the serotonin system: initial studies and future directions[ J]. Eur J Pharmacol, 2000, 410(2-3) : 165-181.
  • 10Pandina GJ, Bossie CA, Youssef E, Zhu Y, Dunbar F. Risperi-done improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial [ J ]. J Autism Dev Disord, 2007, 37(2) :367-373.

共引文献23

同被引文献27

  • 1H6rauh J, Petit E, Martineau J, et al. Serotonin and autism: biochemical and molecular biology features. Psychiatry Re- search, 1996, 1 (65): 33-43.
  • 2Potenza MN, Holmes JP, Kanes SJ, et al. Olanzapine treat-ment of children, adolescents, and adults with pervasive de- velopmental disorders: an open-label pilot study. J Clin Psy- chopharmacol, 1999, 19 (1): 37-44.
  • 3Hollander E, Wasserman S, Swanson EN, et al. A double- blind placebo-controlled pilot study of olanzapine in child- hood/adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology, 2006, 16 (5) : 541-548.
  • 4Kemner C, Willemsen- Swinkels SHN, de Jonge M, et al. Open-label study of olanzapine in children with pervasive de- velopmental disorder. J Clin Psychopharmacol, 2002, 22 (5) : 455-460.
  • 5Fido A, A1-Saad S. Olanzapine in the treatment of behavioral problems associated with autism: an open-label trial in Ku- wait. Med Pfinc Pract. 2008, 17 (5) : 415-418.
  • 6Kirino E. Efficacy and tolerability of pharmaeotherapy options for the treatment of irritability in autistic children. Clin Med Insights Pediatr. 2014, 8: 17-30.
  • 7Malone RP, Cater J, Sheikh RM, et al. Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. J Am Aead Child Adolesc Psychiatry, 2001, 40 (8) : 887-894.
  • 8Politte LC, Mcdougle CJ. Atypical antipsyehoties in the treatment of children and adoleseents with pervasive develop- mental disorders. Psychopharmaeology ( Berl), 2014, 231 (6) : 1023-1036.
  • 9卢建平,闫小华,邓小敏,舒明跃,杨志伟.孤独症儿童及期I级亲属血浆五羟色胺水平的对照研究[J].中国行为医学科学,2008,17(7):617-618. 被引量：1
  • 10刘贤,陈彦平,周雪,王雪莱,孙蒙,梁爽,武丽杰.汉族孤独症谱系障碍儿童脆性X基因突变研究[J].中国儿童保健杂志,2011,19(8):701-703. 被引量：3

引证文献2

二级引证文献5

国际精神病学杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部